The Cancer Prevention and Control (CP) Program faculty and their studies focus on factors affecting Kentucky’s unusually high cancer incidence, morbidity and mortality. Their findings can be used to construct more effective cancer control interventions tailored toward the specific needs and issues faced by this important population.
Learn more by visiting the Cancer Prevention and Control webpage.
The Molecular and Cellular Oncology (MCO) Program faculty and their studies aim to reduce the burden of cancer in Kentucky and the nation by focusing on the unique area of cancer research that integrates signal transduction mechanisms with genetic, epigenetic and metabolic regulation of cancer development and therapeutic resistance.
The Translational Oncology (TO) Program faculty and studies focus on scientifically enhancing the translation of MCC science into impactful clinical trials for our catchment area. TO accomplishes this though validating mechanistic targets in clinically relevant model systems, developing new anticancer agents and devices, advancing these therapies to novel early phase clinical trials and training the next generation of clinician scientists.
Learn more by visiting the Translation Oncology (TO) webpage.